All bills
H.R. 4114·117th Congress·House Bill

Allergy Testing Access Act of 2021

IntroducedTrack

Latest action (24 Jun 2021): Introduced

What this bill does

Plain-English summary

Generate a neutral, plain-English explanation of what this bill does, who it affects and what happens next — grounded in the official text.

Official summary

Allergy Testing Access Act of 2021

This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare.

Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.

Common questions

What does H.R. 4114 do?
Allergy Testing Access Act of 2021 This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare. Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.
Has H.R. 4114 become law?
Not yet. As of 24 Jun 2021, H.R. 4114 is introduced.
Who sponsored H.R. 4114?
H.R. 4114 was sponsored by Rep. Yvette Clarke [D-NY9] (Democrat-NY), with 27 cosponsors.
What's the latest action on H.R. 4114?
Introduced (24 Jun 2021).

Related bills in Health

Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.